Healthcare -
Biotechnology - NASDAQ - US
$ 34.055
1.23 %
$ 14.8 B
Market Cap
17.83
P/E
Price Target
Average
32.14%
Revenue Forecast
Estimate
19.06%
EBIT
Estimate
20.80%
Net Income
Estimate
54.74%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Royalty Pharma plc
Wall Street analysts predict an average 1-year price target for RPRX of $45 , with forecasts ranging from
a
low of
$28 to a high of $51 .
RPRX Lowest Price Target
Wall Street Target
28 USD
-17.78%
RPRX Average Price Target
Wall Street Target
45 USD
32.14%
RPRX Highest Price Target
Wall Street Target
51 USD
49.76%
REVENUE FORECAST
Revenue Forecast Chart RPRX
EBIT FORECAST
EBIT Forecast Chart RPRX
NET INCOME FORECAST
Net Income Chart RPRX